DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: Association and gene-gene interaction study in a population of Central Italy

Neuroscience Letters

Volumn 522, Issue 2, 2012, Pages 103-107

  Mignini, Fiorenzo ^a   Napolioni, Valerio ^a   Codazzo, Claudia ^b   Carpi, Francesco M ^a   Vitali, Mario ^b   Romeo, Marina ^b   Ceccanti, Mauro ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alcohol dependence; Dopamine D2 receptor; Dopamine DAT transporter; Gene gene interaction; Polymorphism

Indexed keywords

DOPAMINE 2 RECEPTOR;

3' UNTRANSLATED REGION; ADULT; AGED; ALCOHOLISM; ALLELE; ARTICLE; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; DSM-IV; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL-RELATED DISORDERS; ALCOHOLISM; CASE-CONTROL STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EPISTASIS, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 84863880071     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.008     Document Type: Article

References (44)

1. Berggren U., Fahlke C., Berglund K.J., Wadell K., Zetterberg H., Blennow K., Thelle D., Balldin J. Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals. Alcohol and Alcoholism 2010, 45:1-5.
2. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience. Brain Research Reviews 1998, 28:309-369.
3. Blum K., Noble E.P., Sheridan P.J., Montgomery A., Ritchie T., Jagadeeswaran P., Nogami H., Briggs A.H., Cohn J.B. Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association 1990, 263:2055-2060.
4. Brisighelli F., Blanco-Verea A., Boschi I., Garagnani P., Pascali V.L., Carracedo A., Capelli C., Salas A. Forensic Science International: Genetics 2012, [Epub ahead of print]. 10.1016/j.fsigen.2012.03.003.
5. Cavallotti C., Mancone M., Bruzzone P., Sabbatini M., Mignini F. Dopamine receptor subtypes in the native human heart. Heart and Vessels 2010, 25:432-437.
6. Cunningham C.L., Howard M.A., Gill S.J., Rubinstein M., Low M.J., Grandy D.K. Ethanol-conditioned place preference in reduced in dopamine D2 receptor deficient mice. Pharmacology Biochemistry and Behavior 2000, 67:693-699.
7. Dahlgren A., Wargelius H.L., Berglund K.J., Fahlke C., Blennow K., Zetterberg H., Oreland L., Berggren U., Balldin J. Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. Alcohol and Alcoholism 2011, 46:509-513.
8. Du Y., Nie Y., Li Y., Wan Y.J. The association between the SLC6A3 VNTR 9-repeat allele and alcoholism - a meta-analysis. Alcoholism, Clinical and Experimental Research 2011, 35:1625-1634.
9. Esposito-Smythers C., Spirito A., Rizzo C., McGeary J.E., Knopik V.S. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacology Biochemistry and Behavior 2009, 3:306-312.
10. 11C-raclopride in man. Synapse 1995, 20:200-208.
11. Flint J., Mackay T.F. Genetic architecture of quantitative traits in mice, flies, and humans. Genome Research 2009, 19:723-733.
12. Fuke S., Sasagawa N., Ishiura S. Identification and characterization of the Hesr/Hey I as a candidate trans-acting factor on gene expression through the 3' non-coding polymorphism region of the human dopamine transporter (DAT1) gene. Journal of Biochemistry 2005, 137:205-216.
13. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics Journal 2001, 1:152-156.
14. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Molecular Pharmacology 1992, 42:383-390.
15. Grandy D.K., Zhang Y., Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Human Molecular Genetics 1993, 2:2197.
16. Guo G., Roettger M.E., Shih J.C. Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescent and young adults. Human Genetics 2007, 121:125-136.
17. Hietala J., West C., Syvalahti E., Nagren K., Lehikoinen P., Sonninen P., Ruotsalainen U. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994, 116:285-290.
18. Hou Q.F., Li S.B. Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neuroscience Letters 2009, 464:127-130.
19. Inoue-Murayama M., Adachi S., Mishima N., Mitani H., Takenaka O., Terao K., Hayasaka I., Ito S., Murayama Y. Variation of variable number of tandem repeat sequences in the 3'-untranslated region of primate dopamine transporter genes that affects reporter gene expression. Neuroscience Letters 2002, 334:206-210.
20. Köhnke M.D., Batra A., Kolb W., Kohnke A.M., Lutz U., Schick S., Gaertner I. Association of the dopamine transporter gene with alcoholism. Alcohol and Alcoholism 2005, 40:339-342.
21. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences 1992, 13:177-184.
22. Laine T.P., Ahonen A., Torniainen P., Heikkla J., Pyhtinen J., Rasanen P., Niemela O., Hillbom M. Dopamine transporters increase in human brain after alcohol withdrawal. Molecular Psychiatry 1999, 4:189-191.
23. Lee K.-W., Kim Y., Kim A.M., Helmin K., Nairn A.C., Greengard P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America 2005, 103:3399-3404.
24. Mignini F., Streccioni V., Amenta F. Autonomic innervation of immune organs and neuroimmune modulation. Autonomic and Autacoid Pharmacology 2003, 23:1-25.
25. Mignini F., Tomassoni D., Traini E., Amenta F. Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen. Journal of Neuroimmunology 2009, 206:5-13.
26. Morozova T.V., Goldman D., Mackay T.F., Anholt R.R. The genetic basis of alcoholism: multiple phenotypes, many genes, complex networks. Genome Biology 2012, 13:239.
27. Munafò M.R., Matheson U., Flint J. Association of DRD2 gene TaqIA polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Molecular Psychiatry 2007, 12:454-461.
28. Myers R.D., Robinson D.E. Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats. Alcohol 1999, 18:225-233.
29. Nelis M., Esko T., Mägi R., Zimprich F., Zimprich A., Toncheva D., Karachanak S., Piskácková T., Balascák I., Peltonen L., Jakkula E., Rehnström K., Lathrop M., Heath S., Galan P., Schreiber S., Meitinger T., Pfeufer A., Wichmann H.E., Melegh B., Polgár N., Toniolo D., Gasparini P., D'Adamo P., Klovins J., Nikitina-Zake L., Kucinskas V., Kasnauskiene J., Lubinski J., Debniak T., Limborska S., Khrunin A., Estivill X., Rabionet R., Marsal S., Julià A., Antonarakis S.E., Deutsch S., Borel C., Attar H., Gagnebin M., Macek M., Krawczak M., Remm M., Metspalu A. Genetic structure of Europeans: a view from the North-East. PLoS One 2009, 4:e5472.
30. Palmer A.A., Low M.J., Grandy D.K., Phillips T.J. Effect of a DRD2 deletion mutation on ethanol-induced locomotor stimulation and sensitization suggest a role for epistasis. Behavior Genetics 2003, 33:311-324.
31. Persico A.M., Vandenbergh D.J., Smith S.S., Uhl G.R. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biological Psychiatry 1993, 34:265-267.
32. Phillips T.J., Brown K.J., Burkhart-Kasch S., Wenger C.D., Kelly M.A., Rubinstein M., Grandy D.K., Low M.J. Alcohol preference and sensitivity are markedly reduced in mice lacking in dopamine D2 receptors. Nature Neuroscience 1998, 1:610-615.
33. Pidoplichko V., De Blasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 1997, 390:401-404.
34. Ponce G., Pérez-Gonzales R., Aragués M., Palomo T., Rodriguez-Jiménez R., Jiménez-Arriero M.A., Hoenicka J. The ANKK1 kinase gene and psychiatric disorders. Neurotoxicity Research 2009, 16:50-59.
35. Risinger F.D., Freeman P.A., Rubinstain M., Low M.J., Grandy D.K. Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice. Psychopharmacology 2000, 152:343-350.
36. Sano A., Kondoh K., Kakimoto Y., Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Human Genetics 1993, 91:405-406.
37. Sansovito A., Cervella P., Selvaggi A., Caviglia G.P., Brgarello G., Sella Salvarani B., Delpero M. DAT1 VNTR polymorphism in a European and an African population: identification of a new allele. Human Biology 2008, 80:191-198.
38. Scafato E., Allamani A., Patussi V., Codenotti T., Marcomini F., Struzzo P. WHO Collaborative Project on Identification and Management of Alcohol-related Problems in Primary Health Care - Report on Phase IV 2005, 131-144. the Italian WHO Phase IV EIBI Working Group, Italy, World Health Organization - Department of Mental Health and Substance Abuse, Geneva, Switzerland. N. Heather (Ed.).
39. Sieminska A., Buczkowski K., Jassem E., Niedosztko M., Tkacz E. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. BMC Medical Genetics 2009, 17:10-92.
40. Smith L., Watson M., Gates S., Ball D., Foxcroft D. Meta-analysis of the association of the T polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. American Journal of Epidemiology 2008, 167:125-138.
41. Thornton-Wells T.A., Moore J.J., Haines J.L. Genetics, statistics and human disease: analytical retooling for complexity. Trends in Genetics 2004, 20:640-647.
42. Van der Zwaluw C.S., Engels R.C., Buitelaar J., Verkes R.J., Franke B., Scholte R.H. Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review. Pharmacogenomics 2009, 10:853-866.
43. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genetics 2005, 6:55.
44. Vaske J., Beaver K.M., Wright J.P., Boisvert D., Schnupp R. An interaction between DAT1 and having an alcoholic father predicts serious alcohol problems in a sample of males. Drug and Alcohol Dependence 2009, 104:17-22.